Chang MN - Search Results

1

Randomized trial of bilateral oophorectomy versus tamoxifen in premenopausal women with metastatic breast cancer.

Ingle JN, Krook JE, Green SJ, Kubista TP, Everson LK, Ahmann DL, Chang MN, Bisel HF, Windschitl HE, Twito DI, et al. Ingle JN, et al. Among authors: chang mn. J Clin Oncol. 1986 Feb;4(2):178-85. doi: 10.1200/JCO.1986.4.2.178. J Clin Oncol. 1986. PMID: 3511184 Clinical Trial.

2

Randomized trial of tamoxifen alone or combined with aminoglutethimide and hydrocortisone in women with metastatic breast cancer.

Ingle JN, Green SJ, Ahmann DL, Long HJ, Edmonson JH, Rubin J, Chang MN, Creagan ET. Ingle JN, et al. Among authors: chang mn. J Clin Oncol. 1986 Jun;4(6):958-64. doi: 10.1200/JCO.1986.4.6.958. J Clin Oncol. 1986. PMID: 3519885 Clinical Trial.

3

Evaluation of bisantrene administered by 72-hour infusion in women with metastatic breast cancer.

Ingle JN, Long HJ, Schutt AJ, Chang MN. Ingle JN, et al. Among authors: chang mn. Am J Clin Oncol. 1986 Oct;9(5):379-81. doi: 10.1097/00000421-198610000-00003. Am J Clin Oncol. 1986. PMID: 3776899

4

Phase II trials of recombinant leukocyte A interferon in disseminated malignant melanoma: results in 96 patients.

Creagan ET, Ahmann DL, Frytak S, Long HJ, Chang MN, Itri LM. Creagan ET, et al. Among authors: chang mn. Cancer Treat Rep. 1986 May;70(5):619-24. Cancer Treat Rep. 1986. PMID: 3518925 Clinical Trial.

5

Phase II study of recombinant interferon-gamma in patients with disseminated malignant melanoma.

Creagan ET, Ahmann DL, Long HJ, Frytak S, Sherwin SA, Chang MN. Creagan ET, et al. Among authors: chang mn. Cancer Treat Rep. 1987 Sep;71(9):843-4. Cancer Treat Rep. 1987. PMID: 3113730

6

Phase II study of mitomycin in disseminated malignant melanoma.

Creagan ET, Edmonson JH, Ahmann DL, Chang M. Creagan ET, et al. Cancer Treat Rep. 1985 Dec;69(12):1451-2. Cancer Treat Rep. 1985. PMID: 4075321 No abstract available.

7

Three consecutive phase II studies of recombinant interferon alfa-2a in advanced malignant melanoma. Updated analyses.

Creagan ET, Ahmann DL, Frytak S, Long HJ, Chang MN, Itri LM. Creagan ET, et al. Among authors: chang mn. Cancer. 1987 Feb 1;59(3 Suppl):638-46. doi: 10.1002/1097-0142(19870201)59:3+<638::aid-cncr2820591312>3.0.co;2-0. Cancer. 1987. PMID: 10822463 Clinical Trial.

8

Phase II studies of single-agent cimetidine and the combination N-phosphonacetyl-L-aspartate (NSC-224131) plus L-alanosine (NSC-153353) in advanced malignant melanoma.

Morton RF, Creagan ET, Cullinan SA, Mailliard JA, Ebbert L, Veeder MH, Chang M. Morton RF, et al. J Clin Oncol. 1987 Jul;5(7):1078-82. doi: 10.1200/JCO.1987.5.7.1078. J Clin Oncol. 1987. PMID: 3598611 Clinical Trial.

9

A phase II clinical trial of the combination mitomycin C, adriamycin, and cis-diamminedichloroplatinum in patients with advanced upper aerodigestive cancer.

Creagan ET, Chang M, Long HJ, Rubin J. Creagan ET, et al. Head Neck Surg. 1986 Jan-Feb;8(3):153-8. doi: 10.1002/hed.2890080305. Head Neck Surg. 1986. PMID: 3091535

10

Phase II study of the combination of carmustine and 6-thioguanine in advanced malignant melanoma.

Morton RF, Creagan ET, Veeder MH, Elson DL, Laurie JA, Nelimark RA, Chang MN. Morton RF, et al. Among authors: chang mn. Cancer Treat Rep. 1987 Apr;71(4):429-30. Cancer Treat Rep. 1987. PMID: 3548962 Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

79 results

Search Page

Filters